Researchers have been investigating the potential benefits of the hemp plant for decades. Even before discovering an entire regulatory system influenced by plant-based cannabinoids in the early 1990s, researchers had been identifying individual plant elements and investigating their potential effects.
Once it was clear that our bodies are essentially wired to respond to hemp and the cannabinoids it contains, a considerable amount of research focused on identifying specific pathways impacted by individual cannabinoids. Although early cannabinoid research was focused on the potential wellness benefits of CBD and THC, the emphasis has since evolved.
Researchers today are also focusing on some of the more than 100 other less concentrated cannabinoids found in industrial hemp. Some are found in such small amounts they are difficult to isolate, while others show considerable health and wellness potential. One of the lesser-known cannabinoids drawing a significant amount of attention, is cannabigerol (CBG).
What Is CBG?
CBG is classified as a minor cannabinoid because mature hemp plants typically contain only trace amounts. The acidic form of CBG, cannabigerolic acid (CBGA), is the first cannabinoid to develop as the plant grows. Eventually, natural plant enzymes convert CBGA to the acidic forms of THC, CBD, CBG, and CBC (cannabichromene). The acidic components are eventually broken down by heat and sunlight. This is why we harvest plants specifically designed to produce higher levels of CBG.